美国 · 财经报刊 · Investor's Business Daily
The Big Caveat Behind Bristol Myers' Sales Guidance Boost
Bristol Myers Squibb stock rose Thursday despite a "mixed bag" performance that included a miss from its biggest cancer drug. The post The Big Caveat Behind Bristol Myers' Sales…
在 Investor's Business Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)
